Product Images Quetiapine Fumarate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Quetiapine Fumarate NDC 65862-876 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 Kaplan-Meier Curves of Time to Schizophrenic Relapse (study 3) - quetiapine fig1
The figure shows Kaplan-Meier curves indicating the time it takes for patients with schizophrenia to experience relapse, obtained from study 3. The x-axis shows the time in months, and the y-axis shows the proportion of patients with relapse. The results include the placebo (PLA) and quetiapine (QTP) treatments, with extended-release (ER) quetiapine also being included. These results are from an interim analysis.*
Figure 3 - quetiapine fig2
This is a figure depicting the Kaplan-Meier Curves demonstrating the time to recurrence of a mood event in Study 9. The y-axis shows the proportion of patients experiencing a relapse as a percentage, and the x-axis shows the time in weeks. No further information or details are provided.*
Figure 3 - quetiapine fig3
This figure shows the Kaplan-Meier curves representing the time to recurrence of a mood event in Study 10. The x-axis shows the time in weeks, and the y-axis represents the proportion of patients with relapse. The percentage value is not provided, indicated by a series of unrelated characters at the bottom of the image.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (60 Tablet Bottle) - quetiapine fig4
This is a medication called Quetiapine Extended-Release, in tablet form, containing 58 mg of quetiapine fumarate, which is equivalent to 50mg quetiapine. It is to be taken once daily and must be swallowed whole. This medication should be kept out of reach of children and stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. It is distributed by Aurobindo Pharma USA, Inc. A medication guide is provided separately to each patient.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 150 mg (60 Tablet Bottle) - quetiapine fig5
This is a prescription drug called Quetiapine Extended-Release. It comes in a film-coated tablet form that contains 173mg of Quetiapine fumarate equivalent to 150mg Quetiapine USP. The recommended dosage is once daily, and it must be swallowed as a whole without chewing, splitting, or crushing. The medication guide provided separately to each patient by the pharmacist must be dispensed. This drug must be kept out of children's reach and stored at USP Controlled Room Temperature of 20° to 25°C (68° to 77°F). The manufacturer is Aurabindo Pharma USA, Inc, and the product is distributed in the US.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg (60 Tablet Bottle) - quetiapine fig6
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (60 Tablet Bottle) - quetiapine fig7
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 400 mg (60 Tablet Bottle) - quetiapine fig8
Chemical Structure - quetiapine str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.